BIOE — Bio Essence Balance Sheet
0.000.00%
- $8.74m
- $9.98m
- $0.32m
Annual balance sheet for Bio Essence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.005 | 0 | 0.006 | 0 | 0.003 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.05 | 0.017 | 0.008 | 0.3 | 0.005 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.33 | 0.262 | 0.204 | 0.3 | 0.281 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.092 | 1.39 | 1.3 | 1.43 | — |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1.85 | 1.7 | 1.55 | 2.76 | 0.281 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.89 | 2.76 | 3.56 | 2.45 | 2.8 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.63 | 4.13 | 4.79 | 4.42 | 3.25 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -1.78 | -2.43 | -3.24 | -1.66 | -2.97 |
Total Liabilities & Shareholders' Equity | 1.85 | 1.7 | 1.55 | 2.76 | 0.281 |
Total Common Shares Outstanding |